290 related articles for article (PubMed ID: 2111665)
1. [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin].
Cassagnes J; Bassand JP; Machecourt J; Lusson JR; Anguenot T; Borel E; Vacher D; Denis B; Maurat JP; Jallut H
Arch Mal Coeur Vaiss; 1990 Apr; 83(4):453-60. PubMed ID: 2111665
[TBL] [Abstract][Full Text] [Related]
2. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
Bassand JP; Machecourt J; Cassagnes J; Anguenot T; Lusson R; Borel E; Peycelon P; Wolf E; Ducellier D
J Am Coll Cardiol; 1989 Apr; 13(5):988-97. PubMed ID: 2647817
[TBL] [Abstract][Full Text] [Related]
3. Effects on infarct size and left ventricular function of early intravenous injection of anistreplase in acute myocardial infarction. The APSIM Study Investigators.
Bassand JP; Bernard Y; Lusson JR; Machecourt J; Cassagnes J; Borel E
Clin Cardiol; 1990 Mar; Suppl 5():V39-44; discussion V67-72. PubMed ID: 2182240
[TBL] [Abstract][Full Text] [Related]
4. Value of myocardial defect size measured by thallium-201 SPECT: results of a multicenter trial comparing heparin and a new fibrinolytic agent.
Maublant JC; Peycelon P; Cardot JC; Verdenet J; Fagret D; Comet M
J Nucl Med; 1988 Sep; 29(9):1486-91. PubMed ID: 3045271
[TBL] [Abstract][Full Text] [Related]
5. Limitation of myocardial infarct size and preservation of left ventricular function by early administration of APSAC in myocardial infarction.
Bassand JP; Machecourt J; Cassagnes J; Lusson JR; Borel E; Schiele F
Am J Cardiol; 1989 Jul; 64(2):18A-23A; discussion 24A-26A. PubMed ID: 2662738
[TBL] [Abstract][Full Text] [Related]
6. Assessment of left ventricular function in a randomised study of intravenous anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction. Preliminary results of the European Multicentre Study (Belgian Centres).
Taeymans Y; Materne P
Drugs; 1987; 33 Suppl 3():216-20. PubMed ID: 3315594
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular function after anisoylated plasminogen streptokinase activator complex.
Been M; Muir AL; de Bono DP
Drugs; 1987; 33 Suppl 3():191-7. PubMed ID: 3315591
[TBL] [Abstract][Full Text] [Related]
8. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
Brochier ML; Quilliet L; Kulbertus H; Materne P; Letac B; Cribier A; Monassier JP; Sacrez A; Favier JP
Drugs; 1987; 33 Suppl 3():140-5. PubMed ID: 3315581
[TBL] [Abstract][Full Text] [Related]
9. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
[TBL] [Abstract][Full Text] [Related]
10. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
[TBL] [Abstract][Full Text] [Related]
11. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction.
Meinertz T; Kasper W; Schumacher M; Just H
Am J Cardiol; 1988 Sep; 62(7):347-51. PubMed ID: 3046283
[TBL] [Abstract][Full Text] [Related]
12. The effect of thrombolytic therapy with anisoylated plasminogen streptokinase activator complex on the indicators of myocardial salvage.
Buchalter MB; Bourke JP; Jennings K; Adams PC; Kenmure AC; Hah CW; Reid DS
Drugs; 1987; 33 Suppl 3():209-15. PubMed ID: 3315593
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic and enzymatic infarct size in a randomised study of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Menlove RL; Anderson JL
Drugs; 1987; 33 Suppl 3():198-208. PubMed ID: 3315592
[TBL] [Abstract][Full Text] [Related]
14. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of APSAC and rt-PA on infarct size and left ventricular function in acute myocardial infarction. A multicenter randomized study.
Bassand JP; Cassagnes J; Machecourt J; Lusson JR; Anguenot T; Wolf JE; Maublant J; Bertrand B; Schiele F
Circulation; 1991 Sep; 84(3):1107-17. PubMed ID: 1909218
[TBL] [Abstract][Full Text] [Related]
16. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
Johnson ES; Cregeen RJ
Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
[TBL] [Abstract][Full Text] [Related]
17. Anisoylated plasminogen streptokinase activator complex in acute myocardial infarction: a placebo-controlled arteriographic coronary recanalization study.
Timmis AD; Griffin B; Crick JC; Sowton E
J Am Coll Cardiol; 1987 Jul; 10(1):205-10. PubMed ID: 3298360
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
Bonnier HJ; Visser RF; Klomps HC; Hoffmann HJ
Am J Cardiol; 1988 Jul; 62(1):25-30. PubMed ID: 3289357
[TBL] [Abstract][Full Text] [Related]
19. Effect of reperfusion on electrocardiographic and enzymatic infarct size: results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction.
Hackworthy RA; Sorensen SG; Fitzpatrick PG; Barry WH; Menlove RL; Rothbard RL; Anderson JL
Am Heart J; 1988 Oct; 116(4):903-14. PubMed ID: 3051985
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
Seabra-Gomes R; Aniceto Silva J; Aleixo A; Real T; Freire I; Torres I; Freitas R; Crespo F
Drugs; 1987; 33 Suppl 3():169-74. PubMed ID: 3315586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
